{"id":2560,"date":"2021-01-27T00:01:48","date_gmt":"2021-01-27T00:01:48","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=2560"},"modified":"2023-08-29T17:48:18","modified_gmt":"2023-08-29T17:48:18","slug":"pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=2560","title":{"rendered":"PharmAust\u5f00\u59cb\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684\u4e0b\u4e00\u6b65\u8bd5\u9a8c"},"content":{"rendered":"<p>\u5728\u83ab\u5948\u592a\u5c14 (MPL)\u6210\u529f\u6cbb\u7597\u72ac\u7c7b\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u4e4b\u540e\uff0c<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=PAA&amp;lang=cn\">PharmAust (ASX: PAA)<\/a>\u7684IIb\u671f\u7814\u7a76\u5df2\u7ecf\u5f00\u59cb\u3002<\/p>\n<p>\u6700\u8fd1\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72acb\u7ec6\u80de\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u5bfc\u81f4\u80bf\u7624\u6d88\u9000\u548c\u75be\u75c5\u7a33\u5b9a\u3002<\/p>\n<p>PharmAust\u9996\u5e2d\u79d1\u5b66\u5b98Richard Mollard\u535a\u58eb\u8bf4:\u201cPharmAust\u5f88\u9ad8\u5174\u80fd\u591f\u91cd\u65b0\u5f00\u59cb\u8fd9\u9879\u4f7f\u7528MPL\u7247\u6cbb\u7597\u5ba0\u7269\u4e3b\u4eba\u7684\u72d7\u60a3b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u8bd5\u9a8c\u3002\u201d<\/p>\n<p>PharmAust\u4e00\u76f4\u5728\u6d4b\u8bd5\u4e24\u4e2a\u72ec\u7acb\u7684\u5047\u8bbe:\u7b2c\u4e00\uff0cMPL\u836f\u7247\u53ef\u4ee5\u4f7f\u764c\u75c7\u6d88\u5931\uff0c\u7b2c\u4e8c\uff0cMPL\u836f\u7247\u53ef\u4ee5\u963b\u6b62\u764c\u75c7\u7684\u53d1\u5c55(\u7a33\u5b9a\u7684\u75be\u75c5)\u3002<\/p>\n<p>\u5728\u5373\u5c06\u5230\u6765\u7684IIb\u671f\u7814\u7a76\u4e2d\uff0cMollard\u535a\u58eb\u8868\u793a\uff0c\u516c\u53f8\u5c06\u4e13\u6ce8\u4e8e\u4f18\u5316\u7ed9\u836f\u65b9\u6848\uff0c\u4f7fMPL\u7684\u6297\u764c\u6d3b\u6027\u6700\u5927\u5316\u3002<\/p>\n<p>\u8fd9\u9879\u7814\u7a76\u7684\u7ed3\u679c\u5c06\u652f\u6301\u5b9a\u4e8e\u4eca\u5e74\u4e0b\u534a\u5e74\u5f00\u59cb\u7684\u4e09\u671f\u7814\u7a76\u3002<\/p>\n<p>\u6b64\u5916\uff0cPharmAust\u6b63\u5728\u4e0e\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u8ba8\u8bba\u7528MPL\u8bc6\u522b\u764c\u75c7\u5e76\u5c06\u5176\u5546\u4e1a\u5316\u3002<\/p>\n<h2>\u7528\u4e8e\u4eba\u4f53\u8bd5\u9a8c\u7684\u83ab\u5948\u592a\u5c14\u7247\u5242<\/h2>\n<p>\u57282020\u5e7412\u6708\u8fd9\u4e2a\u5b63\u5ea6\uff0cPharmAust\u5f00\u59cb\u751f\u4ea710\u516c\u65a4MPL\u7247\u5242\uff0c\u7528\u4e8e\u5373\u5c06\u5230\u6765\u7684\u4eba\u4f53\u8bd5\u9a8c\u548c\u7814\u7a76\u3002<\/p>\n<p>\u5148\u524d\u7684\u4eba\u7c7b\u7814\u7a76\u8868\u660e\uff0c\u4f7f\u7528\u6db2\u4f53MPL\u914d\u65b9\u53ef\u4ee5\u9884\u9632\u80bf\u7624\u8fdb\u5c55\u3002\u7136\u800c\uff0c\u7531\u4e8e\u8fd9\u79cd\u6db2\u4f53\u7684\u201c\u96be\u5403\u6027\u201d\uff0c\u8bd5\u9a8c\u63d0\u524d\u7ec8\u6b62\u4e86\u3002<\/p>\n<p>\u4e3a\u4e86\u89e3\u51b3\u9002\u53e3\u6027\u95ee\u9898\uff0cPharmAust\u5c06MPL\u91cd\u65b0\u914d\u5236\u6210\u7247\u5242\u3002<\/p>\n<p>\u4eba\u7c7b\u764c\u75c7\u4e8c\u671f\u8bd5\u9a8c\u8ba1\u5212\u660e\u5e74\u521d\u5f00\u59cb\u3002<\/p>\n<p>\u4e0e\u6b64\u540c\u65f6\uff0c\u8fdb\u4e00\u6b65\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u6b63\u5728\u4e0e\u5965\u5229\u7ef4\u4e9a\u00b7\u725b\u987f-\u7ea6\u7ff0\u764c\u75c7\u7814\u7a76\u6240\uff08Olivia Newton-John Cancer Research Institute\uff09\u8fdb\u884c\u5408\u4f5c\u3002<\/p>\n<p>\u201cPharmAust\u5e0c\u671b\u5728\u5206\u5b50\u6c34\u5e73\u4e0a\u770b\u5230MPL\u5982\u4f55\u5728\u7ec6\u80de\u4e2d\u5de5\u4f5c\u4ee5\u5bf9\u6297\u75be\u75c5\uff0c\u7279\u522b\u662fMPL\u7684\u4f5c\u7528\u673a\u5236\u5982\u4f55\u4e0d\u540c\u4e8e\u76ee\u524d\u4e34\u5e8a\u4e2d\u7684\u5176\u4ed6mTOR\u6291\u5236\u5242\uff0c\u201dMollard\u535a\u58eb\u8bf4\u3002<\/p>\n<h2>\u5728\u5176\u4ed6\u6761\u4ef6\u4e0b\u4f7f\u7528\u83ab\u5948\u592a\u5c14<\/h2>\n<p>\u9664\u4e86\u4f7f\u7528MPL\u6cbb\u7597\u764c\u75c7\u5916\uff0cPharmAust\u8fd8\u5728\u8c03\u67e5MPL\u5bf9\u5305\u62ec\u75ab\u60c5\u5728\u5185\u7684\u5176\u4ed6\u75be\u75c5\u7684\u5f71\u54cd\u3002<\/p>\n<p>\u53bb\u5e74\u7b2c\u56db\u5b63\u5ea6\uff0cPharmAust\u4e0e\u8377\u5170\u7814\u7a76\u4eba\u5458\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u8bc4\u4f30MPL\u548c\u83ab\u5948\u592a\u5c14\u781c\u5bf9\u7ec6\u80de\u5185SARS-CoV-2\u7684\u5f71\u54cd\u3002<\/p>\n<p>\u7814\u7a76\u7684\u6700\u7ec8\u62a5\u544a\u201c\u5373\u5c06\u51fa\u7089\u201d\u3002<\/p>\n<p>PharmAust\u6307\u51fa\uff0cMPL\u53ef\u80fd\u6bd4\u5176\u4ed6\u6b63\u5728\u5f00\u53d1\u7684\u6cbb\u7597\u8be5\u75c5\u6bd2\u7684\u836f\u7269\u5177\u6709\u201c\u660e\u663e\u7684\u4f18\u52bf\u201d\uff0c\u56e0\u4e3a\u5b83\u5df2\u7ecf\u5728\u4eba\u4f53\u8bd5\u9a8c\u4e2d\u4f7f\u7528\uff0c\u800c\u4e14\u5177\u6709\u201c\u9ad8\u201d\u5b89\u5168\u6027\u3002<\/p>\n<p>\u6b64\u5916\uff0c\u76ee\u524d\u552f\u4e00\u6279\u51c6\u7684\u6cbb\u7597\u745e\u5fb7\u897f\u97e6\u9700\u8981\u9759\u8109\u6ce8\u5c04\uff0c\u800cMPL\u53ef\u4ee5\u4ee5\u7247\u5242\u5f62\u5f0f\u7ed9\u4e88\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u8865\u5145\u79f0:\u201c\u8fd9\u610f\u5473\u7740\u60a3\u8005\u53ef\u4ee5\u5728\u9996\u6b21\u68c0\u6d4b\u5448\u9633\u6027\u65f6\u66f4\u65e9\u63a5\u53d7\u6cbb\u7597\uff0c\u800c\u4e0d\u662f\u56e0\u51a0\u72b6\u75c5\u6bd2\u4f4f\u9662\u7684\u91cd\u75c7\u76d1\u62a4\u60a3\u8005\u3002\u201d<\/p>\n<p>PharmAust\u4e5f\u5728\u7814\u7a76\u7528MPL\u6cbb\u7597\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u5df2\u5f00\u59cb\u4e3a\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u505a\u51c6\u5907\uff0c\u201c\u5c3d\u5feb\u201d\u5f00\u59cb\u62db\u8058\u3002<\/p>\n<h2>Epichem<\/h2>\n<p>PharmAust\u7684\u5168\u8d44\u5b50\u516c\u53f8Epichem\u572812\u6708\u7684\u5b63\u5ea6\u7ee7\u7eed\u5efa\u7acb\u81ea\u5df1\u7684\u77e5\u8bc6\u4ea7\u6743\u7ec4\u5408\u3002<\/p>\n<p>\u8fd9\u5305\u62ec\u6267\u884c\u4e00\u9879\u4e3b\u8981\u534f\u8bae\uff0c\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u53ef\u5c06\u5e9f\u7269\u8f6c\u5316\u4e3a\u71c3\u6599\u7684\u751f\u7269\u8d28\/\u539f\u6599\u6c27\u5316\u8fc7\u7a0b\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5728\u83ab\u5948\u592a\u5c14 (MPL)\u6210\u529f\u6cbb\u7597\u72ac\u7c7b\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u4e4b\u540e\uff0cPharmAust (ASX: PAA)\u7684IIb\u671f\u7814\u7a76\u5df2\u7ecf\u5f00\u59cb\u3002 \u6700\u8fd1\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72acb\u7ec6\u80de\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u5bfc\u81f4\u80bf\u7624\u6d88\u9000\u548c\u75be\u75c5\u7a33\u5b9a\u3002 PharmAust\u9996\u5e2d\u79d1\u5b66\u5b98Richard Mollard\u535a\u58eb\u8bf4:\u201cPharmAust\u5f88\u9ad8\u5174\u80fd\u591f\u91cd\u65b0\u5f00\u59cb\u8fd9\u9879\u4f7f\u7528MPL\u7247\u6cbb\u7597\u5ba0\u7269\u4e3b\u4eba\u7684\u72d7\u60a3b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u8bd5\u9a8c\u3002\u201d PharmAust\u4e00\u76f4\u5728\u6d4b\u8bd5\u4e24\u4e2a\u72ec\u7acb\u7684\u5047\u8bbe:\u7b2c\u4e00\uff0cMPL\u836f\u7247\u53ef\u4ee5\u4f7f\u764c\u75c7\u6d88\u5931\uff0c\u7b2c\u4e8c\uff0cMPL\u836f\u7247\u53ef\u4ee5\u963b\u6b62\u764c\u75c7\u7684\u53d1\u5c55(\u7a33\u5b9a\u7684\u75be\u75c5)\u3002 \u5728\u5373\u5c06\u5230\u6765\u7684IIb\u671f\u7814\u7a76\u4e2d\uff0cMollard\u535a\u58eb\u8868\u793a\uff0c\u516c\u53f8\u5c06\u4e13\u6ce8\u4e8e\u4f18\u5316\u7ed9\u836f\u65b9\u6848\uff0c\u4f7fMPL\u7684\u6297\u764c\u6d3b\u6027\u6700\u5927\u5316\u3002 \u8fd9\u9879\u7814\u7a76\u7684\u7ed3\u679c\u5c06\u652f\u6301\u5b9a\u4e8e\u4eca\u5e74\u4e0b\u534a\u5e74\u5f00\u59cb\u7684\u4e09\u671f\u7814\u7a76\u3002 \u6b64\u5916\uff0cPharmAust\u6b63\u5728\u4e0e\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u8ba8\u8bba\u7528MPL\u8bc6\u522b\u764c\u75c7\u5e76\u5c06\u5176\u5546\u4e1a\u5316\u3002 \u7528\u4e8e\u4eba\u4f53\u8bd5\u9a8c\u7684\u83ab\u5948\u592a\u5c14\u7247\u5242 \u57282020\u5e7412\u6708\u8fd9\u4e2a\u5b63\u5ea6\uff0cPharmAust\u5f00\u59cb\u751f\u4ea710\u516c\u65a4MPL\u7247\u5242\uff0c\u7528\u4e8e\u5373\u5c06\u5230\u6765\u7684\u4eba\u4f53\u8bd5\u9a8c\u548c\u7814\u7a76\u3002 \u5148\u524d\u7684\u4eba\u7c7b\u7814\u7a76\u8868\u660e\uff0c\u4f7f\u7528\u6db2\u4f53MPL\u914d\u65b9\u53ef\u4ee5\u9884\u9632\u80bf\u7624\u8fdb\u5c55\u3002\u7136\u800c\uff0c\u7531\u4e8e\u8fd9\u79cd\u6db2\u4f53\u7684\u201c\u96be\u5403\u6027\u201d\uff0c\u8bd5\u9a8c\u63d0\u524d\u7ec8\u6b62\u4e86\u3002 \u4e3a\u4e86\u89e3\u51b3\u9002\u53e3\u6027\u95ee\u9898\uff0cPharmAust\u5c06MPL\u91cd\u65b0\u914d\u5236\u6210\u7247\u5242\u3002 \u4eba\u7c7b\u764c\u75c7\u4e8c\u671f\u8bd5\u9a8c\u8ba1\u5212\u660e\u5e74\u521d\u5f00\u59cb\u3002 \u4e0e\u6b64\u540c\u65f6\uff0c\u8fdb\u4e00\u6b65\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u6b63\u5728\u4e0e\u5965\u5229\u7ef4\u4e9a\u00b7\u725b\u987f-\u7ea6\u7ff0\u764c\u75c7\u7814\u7a76\u6240\uff08Olivia Newton-John Cancer Research Institute\uff09\u8fdb\u884c\u5408\u4f5c\u3002 \u201cPharmAust\u5e0c\u671b\u5728\u5206\u5b50\u6c34\u5e73\u4e0a\u770b\u5230MPL\u5982\u4f55\u5728\u7ec6\u80de\u4e2d\u5de5\u4f5c\u4ee5\u5bf9\u6297\u75be\u75c5\uff0c\u7279\u522b\u662fMPL\u7684\u4f5c\u7528\u673a\u5236\u5982\u4f55\u4e0d\u540c\u4e8e\u76ee\u524d\u4e34\u5e8a\u4e2d\u7684\u5176\u4ed6mTOR\u6291\u5236\u5242\uff0c\u201dMollard\u535a\u58eb\u8bf4\u3002 \u5728\u5176\u4ed6\u6761\u4ef6\u4e0b\u4f7f\u7528\u83ab\u5948\u592a\u5c14 \u9664\u4e86\u4f7f\u7528MPL\u6cbb\u7597\u764c\u75c7\u5916\uff0cPharmAust\u8fd8\u5728\u8c03\u67e5MPL\u5bf9\u5305\u62ec\u75ab\u60c5\u5728\u5185\u7684\u5176\u4ed6\u75be\u75c5\u7684\u5f71\u54cd\u3002 \u53bb\u5e74\u7b2c\u56db\u5b63\u5ea6\uff0cPharmAust\u4e0e\u8377\u5170\u7814\u7a76\u4eba\u5458\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u8bc4\u4f30MPL\u548c\u83ab\u5948\u592a\u5c14\u781c\u5bf9\u7ec6\u80de\u5185SARS-CoV-2\u7684\u5f71\u54cd\u3002 \u7814\u7a76\u7684\u6700\u7ec8\u62a5\u544a\u201c\u5373\u5c06\u51fa\u7089\u201d\u3002 PharmAust\u6307\u51fa\uff0cMPL\u53ef\u80fd\u6bd4\u5176\u4ed6\u6b63\u5728\u5f00\u53d1\u7684\u6cbb\u7597\u8be5\u75c5\u6bd2\u7684\u836f\u7269\u5177\u6709\u201c\u660e\u663e\u7684\u4f18\u52bf\u201d\uff0c\u56e0\u4e3a\u5b83\u5df2\u7ecf\u5728\u4eba\u4f53\u8bd5\u9a8c\u4e2d\u4f7f\u7528\uff0c\u800c\u4e14\u5177\u6709\u201c\u9ad8\u201d\u5b89\u5168\u6027\u3002 \u6b64\u5916\uff0c\u76ee\u524d\u552f\u4e00\u6279\u51c6\u7684\u6cbb\u7597\u745e\u5fb7\u897f\u97e6\u9700\u8981\u9759\u8109\u6ce8\u5c04\uff0c\u800cMPL\u53ef\u4ee5\u4ee5\u7247\u5242\u5f62\u5f0f\u7ed9\u4e88\u3002 \u8be5\u516c\u53f8\u8865\u5145\u79f0:\u201c\u8fd9\u610f\u5473\u7740\u60a3\u8005\u53ef\u4ee5\u5728\u9996\u6b21\u68c0\u6d4b\u5448\u9633\u6027\u65f6\u66f4\u65e9\u63a5\u53d7\u6cbb\u7597\uff0c\u800c\u4e0d\u662f\u56e0\u51a0\u72b6\u75c5\u6bd2\u4f4f\u9662\u7684\u91cd\u75c7\u76d1\u62a4\u60a3\u8005\u3002\u201d PharmAust\u4e5f\u5728\u7814\u7a76\u7528MPL\u6cbb\u7597\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5\u3002 \u8be5\u516c\u53f8\u5df2\u5f00\u59cb\u4e3a\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u505a\u51c6\u5907\uff0c\u201c\u5c3d\u5feb\u201d\u5f00\u59cb\u62db\u8058\u3002 Epichem PharmAust\u7684\u5168\u8d44\u5b50\u516c\u53f8Epichem\u572812\u6708\u7684\u5b63\u5ea6\u7ee7\u7eed\u5efa\u7acb\u81ea\u5df1\u7684\u77e5\u8bc6\u4ea7\u6743\u7ec4\u5408\u3002 \u8fd9\u5305\u62ec\u6267\u884c\u4e00\u9879\u4e3b\u8981\u534f\u8bae\uff0c\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u53ef\u5c06\u5e9f\u7269\u8f6c\u5316\u4e3a\u71c3\u6599\u7684\u751f\u7269\u8d28\/\u539f\u6599\u6c27\u5316\u8fc7\u7a0b\u3002<\/p>\n","protected":false},"author":3,"featured_media":10615,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[241],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PharmAust\u5f00\u59cb\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684\u4e0b\u4e00\u6b65\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"\u5728\u83ab\u5948\u592a\u5c14 (MPL)\u6210\u529f\u6cbb\u7597\u72ac\u7c7b\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u4e4b\u540e\uff0cPharmAust (ASX: PAA)\u7684IIb\u671f\u7814\u7a76\u5df2\u7ecf\u5f00\u59cb\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PharmAust\u5f00\u59cb\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684\u4e0b\u4e00\u6b65\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"\u5728\u83ab\u5948\u592a\u5c14 (MPL)\u6210\u529f\u6cbb\u7597\u72ac\u7c7b\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u4e4b\u540e\uff0cPharmAust (ASX: PAA)\u7684IIb\u671f\u7814\u7a76\u5df2\u7ecf\u5f00\u59cb\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-27T00:01:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:48:18+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/PharmAust-PAA-ASX-monepantel-MPL-canine-dog-cancer-B-cell-lymphoma-quarterly-December-2020.jpg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"PharmAust\u5f00\u59cb\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684\u4e0b\u4e00\u6b65\u8bd5\u9a8c\" \/>\n<meta name=\"twitter:description\" content=\"\u5728\u83ab\u5948\u592a\u5c14 (MPL)\u6210\u529f\u6cbb\u7597\u72ac\u7c7b\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u4e4b\u540e\uff0cPharmAust (ASX: PAA)\u7684IIb\u671f\u7814\u7a76\u5df2\u7ecf\u5f00\u59cb\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/PharmAust-PAA-ASX-monepantel-MPL-canine-dog-cancer-B-cell-lymphoma-quarterly-December-2020.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/\",\"name\":\"PharmAust\u5f00\u59cb\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684\u4e0b\u4e00\u6b65\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-01-27T00:01:48+00:00\",\"dateModified\":\"2023-08-29T17:48:18+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"\u5728\u83ab\u5948\u592a\u5c14 (MPL)\u6210\u529f\u6cbb\u7597\u72ac\u7c7b\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u4e4b\u540e\uff0cPharmAust (ASX: PAA)\u7684IIb\u671f\u7814\u7a76\u5df2\u7ecf\u5f00\u59cb\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PharmAust\u5f00\u59cb\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684\u4e0b\u4e00\u6b65\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"PharmAust\u5f00\u59cb\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684\u4e0b\u4e00\u6b65\u8bd5\u9a8c","description":"\u5728\u83ab\u5948\u592a\u5c14 (MPL)\u6210\u529f\u6cbb\u7597\u72ac\u7c7b\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u4e4b\u540e\uff0cPharmAust (ASX: PAA)\u7684IIb\u671f\u7814\u7a76\u5df2\u7ecf\u5f00\u59cb\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"PharmAust\u5f00\u59cb\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684\u4e0b\u4e00\u6b65\u8bd5\u9a8c","og_description":"\u5728\u83ab\u5948\u592a\u5c14 (MPL)\u6210\u529f\u6cbb\u7597\u72ac\u7c7b\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u4e4b\u540e\uff0cPharmAust (ASX: PAA)\u7684IIb\u671f\u7814\u7a76\u5df2\u7ecf\u5f00\u59cb\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/","og_site_name":"smallcapsCN","article_published_time":"2021-01-27T00:01:48+00:00","article_modified_time":"2023-08-29T17:48:18+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/PharmAust-PAA-ASX-monepantel-MPL-canine-dog-cancer-B-cell-lymphoma-quarterly-December-2020.jpg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_title":"PharmAust\u5f00\u59cb\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684\u4e0b\u4e00\u6b65\u8bd5\u9a8c","twitter_description":"\u5728\u83ab\u5948\u592a\u5c14 (MPL)\u6210\u529f\u6cbb\u7597\u72ac\u7c7b\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u4e4b\u540e\uff0cPharmAust (ASX: PAA)\u7684IIb\u671f\u7814\u7a76\u5df2\u7ecf\u5f00\u59cb\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/PharmAust-PAA-ASX-monepantel-MPL-canine-dog-cancer-B-cell-lymphoma-quarterly-December-2020.jpg","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/","url":"https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/","name":"PharmAust\u5f00\u59cb\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684\u4e0b\u4e00\u6b65\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-01-27T00:01:48+00:00","dateModified":"2023-08-29T17:48:18+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"\u5728\u83ab\u5948\u592a\u5c14 (MPL)\u6210\u529f\u6cbb\u7597\u72ac\u7c7b\u6dcb\u5df4\u7624\u7684IIa\u671f\u8bd5\u9a8c\u4e4b\u540e\uff0cPharmAust (ASX: PAA)\u7684IIb\u671f\u7814\u7a76\u5df2\u7ecf\u5f00\u59cb\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"PharmAust\u5f00\u59cb\u4f7f\u7528\u83ab\u5948\u592a\u5c14\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684\u4e0b\u4e00\u6b65\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2560"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2560"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2560\/revisions"}],"predecessor-version":[{"id":10614,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2560\/revisions\/10614"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/10615"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}